+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Contract Manufacturing & Research Services Market by Service Type, Molecule Type, Dosage Form, Application - Global Forecast 2026-2032- Product Image
Pharmaceutical Contract Manufacturing & Research Services Market by Service Type, Molecule Type, Dosage Form, Application - Global Forecast 2026-2032- Product Image
Sale

Pharmaceutical Contract Manufacturing & Research Services Market by Service Type, Molecule Type, Dosage Form, Application - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5454990
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical Contract Manufacturing & Research Services Market is projected to reach USD 237.20 Billion in 2026. It is expected to continue growing at a CAGR of 10.92%, reaching USD 444.03 Billion by 2032.

Pharmaceutical contract manufacturing and research services are moving from tactical outsourcing to a strategic operating model for drug developers, biotechnology companies, and specialty pharmaceutical firms. Contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) support discovery, preclinical research, clinical trial execution, regulatory submissions, API manufacturing, biologics production, sterile fill-finish, packaging, and post-approval lifecycle management.

Demand is anchored in measurable industry realities: the U.S. FDA Center for Drug Evaluation and Research approved 55 novel drugs in 2023 and 50 in 2024, while biologics, orphan drugs, oncology therapies, and complex modalities continue to increase development and manufacturing intensity. Sponsors are using external partners to access GMP capacity, scientific expertise, digital trial infrastructure, and global regulatory knowledge without carrying the full fixed-cost burden of in-house assets.

Transformative Shifts in the Pharmaceutical Outsourcing Landscape

The outsourcing landscape is being reshaped by biologics, high-potency APIs, antibody-drug conjugates, mRNA platforms, cell and gene therapies, and sterile injectables. These categories require specialized containment, aseptic processing, analytical characterization, cold-chain logistics, and validated quality systems, increasing the strategic value of CDMO and CRO partnerships.

At the same time, sponsors are rebalancing supply chains after pandemic-era disruptions, raw material constraints, and geopolitical trade risks. Nearshoring, dual sourcing, and regional redundancy are becoming standard procurement priorities. Regulatory expectations are also rising through ICH quality guidelines, FDA quality management maturity initiatives, EU GMP requirements, and data integrity enforcement, making proven compliance performance a decisive differentiator for pharmaceutical outsourcing partners.

Cumulative Impact of Artificial Intelligence on CDMO and CRO Operations

Artificial intelligence is becoming a cumulative productivity layer across pharmaceutical contract research and manufacturing. In drug discovery and preclinical research, AI-enabled modeling supports target identification, molecule screening, toxicology prediction, and protocol design. In clinical development, machine learning helps identify patient cohorts, optimize site selection, monitor trial risk, and improve decentralized trial operations.

In manufacturing, AI supports process analytical technology, predictive maintenance, deviation detection, batch-release acceleration, and yield improvement. The greatest impact is expected where AI is deployed within validated GxP frameworks, supported by auditable data lineage, cybersecurity controls, and human scientific oversight. For CDMOs and CROs, AI capability is becoming a commercial advantage rather than a back-office experiment.

Key Regional Insights Across Global Pharmaceutical Outsourcing

Asia-Pacific is a major hub for pharmaceutical contract manufacturing and research services, supported by large patient populations, competitive operating costs, expanding biologics investment, and mature capabilities in China, India, Japan, South Korea, Australia, and ASEAN markets. North America remains a premium innovation and outsourcing center, led by the United States and Canada, where venture-backed biotechnology, FDA-regulated manufacturing, and advanced clinical trial networks support high-value demand.

Europe maintains strength in quality-driven CDMO services, advanced therapies, and regulated clinical research, supported by EMA oversight and deep expertise in Germany, France, Italy, Spain, and the United Kingdom. Latin America, led by Brazil and Mexico, is gaining importance for clinical trial recruitment, regional packaging, and access to treatment-naive patient populations. The Middle East is investing in pharmaceutical localization and health security, while Africa offers long-term potential as regulatory harmonization, vaccine manufacturing investment, and clinical research infrastructure improve.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN is strengthening its role in contract research, packaging, generics manufacturing, and regional supply chain diversification as Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines expand healthcare investment and regulatory cooperation. The GCC is prioritizing pharmaceutical localization, biologics access, and sovereign medicine security through national industrial strategies, public procurement reforms, and investments in local manufacturing capacity.

The European Union remains a regulatory benchmark for GMP, pharmacovigilance, and clinical research standards, making EU-based CDMOs and CROs attractive for complex programs. BRICS economies are central to API supply, generics scale, patient recruitment, and domestic innovation. G7 countries dominate high-value R&D, advanced therapy commercialization, and regulatory science, while NATO-aligned markets increasingly view pharmaceutical supply resilience, essential medicines availability, and critical input security as strategic priorities.

Key Country Insights for Pharmaceutical CDMO and CRO Strategy

The United States is an innovation-led outsourcing market with strong demand for biologics, sterile injectables, clinical trials, and advanced therapies supported by FDA regulatory pathways and a deep biotechnology ecosystem. Canada offers research depth, established academic networks, and a favorable clinical development environment, while Mexico benefits from proximity to the United States and nearshoring opportunities for packaging, logistics, and selected manufacturing activities. Brazil is Latin America's anchor for clinical research participation, regulatory modernization, and regional pharmaceutical demand.

The United Kingdom, Germany, France, Italy, and Spain remain central to European contract research and GMP manufacturing, with Germany and France particularly strong in high-quality industrial capabilities and regulated production. Russia retains domestic manufacturing needs but faces geopolitical constraints affecting international collaboration and supply chain access. China and India are major engines for API production, generics manufacturing, biologics investment, and clinical research capacity. Japan emphasizes quality, innovation, and regulated development pathways, Australia is valued for early-phase trials and R&D incentives, and South Korea is recognized for biologics CDMO scale, advanced manufacturing infrastructure, and export-oriented pharmaceutical capabilities.

Actionable Recommendations for Pharmaceutical Outsourcing Leaders

Industry leaders should build outsourcing portfolios around resilience, quality maturity, and technical fit rather than lowest unit cost. Sponsors should qualify secondary suppliers for critical APIs, sterile capacity, and single-use biologics inputs while using risk-based vendor governance aligned with ICH Q9 and ICH Q10 principles.

CDMOs and CROs should invest in differentiated capabilities, including high-potency containment, aseptic fill-finish, biologics characterization, decentralized trial platforms, real-world evidence analytics, and AI-enabled quality systems. Commercial teams should emphasize regulatory track record, inspection history, data integrity, on-time delivery, and technology transfer performance. Leaders that combine scientific specialization with flexible capacity and transparent digital collaboration will be best positioned to win long-term strategic partnerships.

Research Methodology and Data Validation Approach

This executive summary is developed using a structured secondary-research methodology focused on verified public-domain sources, regulatory guidance, industry disclosures, regulatory filings, and authoritative healthcare datasets. Core inputs include FDA, EMA, ICH, WHO, national regulatory agencies, clinical trial registries, peer-reviewed literature, public financial reports, and recognized pharmaceutical industry analyses.

The methodology emphasizes triangulation across demand indicators, regulatory developments, manufacturing capacity signals, therapeutic modality trends, and regional policy initiatives. Insights are validated for consistency, relevance, and recency, with preference given to evidence that can be corroborated through multiple reputable sources. The analysis avoids unsupported forecasts and focuses on operational, regulatory, and market dynamics that directly affect pharmaceutical contract manufacturing and research services.

Conclusion: Strategic Outlook for Pharmaceutical Outsourcing

Pharmaceutical contract manufacturing and research services are becoming essential to the global drug development value chain. As product pipelines become more complex and regulatory expectations rise, sponsors increasingly need specialized partners that can deliver scientific expertise, compliant execution, and scalable capacity across the product lifecycle.

The competitive landscape will favor CDMOs and CROs that combine quality excellence, advanced modality capabilities, digital maturity, and regional resilience. Artificial intelligence, strategic supply chain redesign, and expanding global clinical research networks will further redefine outsourcing models. Organizations that act now to strengthen partnerships, diversify supply, and modernize operations will be better positioned to accelerate development timelines and protect long-term value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pharmaceutical Contract Manufacturing & Research Services Market, by Service Type
7.1. Drug Substance Manufacturing
7.2. Drug Product Manufacturing
7.3. Packaging & Finishing
7.4. Development Services
7.5. Clinical Trial Services
7.6. Laboratory & Testing Services
7.6.1. Quality Control & Release Testing
7.6.2. Stability Studies
7.6.3. Bioanalytical & Microbiology Testing
8. Pharmaceutical Contract Manufacturing & Research Services Market, by Molecule Type
8.1. Small Molecules
8.2. Biologics
8.3. Advanced Therapies
9. Pharmaceutical Contract Manufacturing & Research Services Market, by Dosage Form
9.1. Oral Solid
9.2. Oral Liquid
9.3. Inhalation & Nasal
9.4. Ophthalmic
10. Pharmaceutical Contract Manufacturing & Research Services Market, by Application
10.1. Oncology
10.2. Cardiovascular & Metabolic
10.3. Central Nervous System
10.4. Infectious Diseases
10.5. Immunology & Inflammation
10.6. Respiratory
10.7. Gastrointestinal & Hepatology
10.8. Dermatology
10.9. Ophthalmology
10.10. Rare Diseases & Orphan
11. Asia-Pacific Pharmaceutical Contract Manufacturing & Research Services Market
12. North America Pharmaceutical Contract Manufacturing & Research Services Market
13. Latin America Pharmaceutical Contract Manufacturing & Research Services Market
14. Europe Pharmaceutical Contract Manufacturing & Research Services Market
15. Middle East Pharmaceutical Contract Manufacturing & Research Services Market
16. Africa Pharmaceutical Contract Manufacturing & Research Services Market
17. ASEAN Pharmaceutical Contract Manufacturing & Research Services Market
18. GCC Pharmaceutical Contract Manufacturing & Research Services Market
19. European Union Pharmaceutical Contract Manufacturing & Research Services Market
20. BRICS Pharmaceutical Contract Manufacturing & Research Services Market
21. G7 Pharmaceutical Contract Manufacturing & Research Services Market
22. NATO Pharmaceutical Contract Manufacturing & Research Services Market
23. United States Pharmaceutical Contract Manufacturing & Research Services Market
24. Canada Pharmaceutical Contract Manufacturing & Research Services Market
25. Mexico Pharmaceutical Contract Manufacturing & Research Services Market
26. Brazil Pharmaceutical Contract Manufacturing & Research Services Market
27. United Kingdom Pharmaceutical Contract Manufacturing & Research Services Market
28. Germany Pharmaceutical Contract Manufacturing & Research Services Market
29. France Pharmaceutical Contract Manufacturing & Research Services Market
30. Russia Pharmaceutical Contract Manufacturing & Research Services Market
31. Italy Pharmaceutical Contract Manufacturing & Research Services Market
32. Spain Pharmaceutical Contract Manufacturing & Research Services Market
33. China Pharmaceutical Contract Manufacturing & Research Services Market
34. India Pharmaceutical Contract Manufacturing & Research Services Market
35. Japan Pharmaceutical Contract Manufacturing & Research Services Market
36. Australia Pharmaceutical Contract Manufacturing & Research Services Market
37. South Korea Pharmaceutical Contract Manufacturing & Research Services Market
38. Competitive Landscape
38.1. Market Concentration Analysis, 2025
38.1.1. Concentration Ratio (CR)
38.1.2. Herfindahl Hirschman Index (HHI)
38.2. Recent Developments & Impact Analysis, 2025
38.3. Product Portfolio Analysis, 2025
38.4. Benchmarking Analysis, 2025
39. Company Profiles
39.1. AbbVie Inc
39.2. Almac Group
39.3. Amanta Healthcare Ltd.
39.4. Aragen Life Sciences Ltd.
39.5. Automatic Liquid Packaging Solutions LLC
39.6. Baxter Pharmaceutical Solutions LLC
39.7. Boehringer Ingelheim International GmbH
39.8. Cambrex Corporation
39.9. Catalent, Inc
39.10. Curida AS
39.11. Dalton Pharma Services
39.12. Evonik Industries AG
39.13. Famar Group
39.14. Horizon Pharmaceuticals, Inc
39.15. Laboratorios SALVAT, S.A
39.16. Lonza Group Ltd.
39.17. Nephron Pharmaceuticals Corporation
39.18. Pfizer, Inc.
39.19. Recipharm AB
39.20. Rommelag SE & Co. KG
39.21. Rusoma Laboratories Private Limited
39.22. Silgan Unicep
39.23. Unither Pharmaceuticals SAS
39.24. UPM Pharmaceuticals, Inc.
39.25. Woodstock Sterile Solutions
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 35. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. GCC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. GCC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. G7 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. G7 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. NATO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. NATO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 47. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 48. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG SUBSTANCE MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DRUG SUBSTANCE MANUFACTURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DRUG SUBSTANCE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DRUG PRODUCT MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DRUG PRODUCT MANUFACTURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DRUG PRODUCT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PACKAGING & FINISHING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PACKAGING & FINISHING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PACKAGING & FINISHING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DEVELOPMENT SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DEVELOPMENT SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL LABORATORY & TESTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL LABORATORY & TESTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL LABORATORY & TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL QUALITY CONTROL & RELEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL QUALITY CONTROL & RELEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL QUALITY CONTROL & RELEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL STABILITY STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL STABILITY STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL STABILITY STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIOANALYTICAL & MICROBIOLOGY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOANALYTICAL & MICROBIOLOGY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOANALYTICAL & MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SMALL MOLECULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SMALL MOLECULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SMALL MOLECULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ADVANCED THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ADVANCED THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ADVANCED THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ORAL SOLID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ORAL SOLID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ORAL SOLID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ORAL LIQUID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ORAL LIQUID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ORAL LIQUID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL INHALATION & NASAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL INHALATION & NASAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL INHALATION & NASAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL OPHTHALMIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL OPHTHALMIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL OPHTHALMIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CARDIOVASCULAR & METABOLIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CARDIOVASCULAR & METABOLIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CARDIOVASCULAR & METABOLIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CENTRAL NERVOUS SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CENTRAL NERVOUS SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CENTRAL NERVOUS SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RESPIRATORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL RESPIRATORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RESPIRATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GASTROINTESTINAL & HEPATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GASTROINTESTINAL & HEPATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GASTROINTESTINAL & HEPATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DERMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL RARE DISEASES & ORPHAN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL RARE DISEASES & ORPHAN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RARE DISEASES & ORPHAN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 110. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 111. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 113. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 122. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 123. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 124. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 125. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 126. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 128. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 129. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 130. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 131. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. GCC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GCC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 134. GCC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 135. GCC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 136. GCC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 137. GCC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 146. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 147. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 148. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 149. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. G7 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. G7 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 152. G7 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 153. G7 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 154. G7 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 155. G7 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. NATO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. NATO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 158. NATO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 159. NATO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 160. NATO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 161. NATO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 164. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 165. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 167. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 169. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 170. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 171. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 172. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 173. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 175. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 176. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 177. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 178. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 179. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 181. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 182. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 183. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 184. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 185. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 187. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 188. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 189. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 190. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 191. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 192. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 193. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 194. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 195. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 196. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 197. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 199. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 200. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 201. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 202. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 203. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 205. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 206. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 207. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 208. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 209. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 211. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 212. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 213. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 214. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 215. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 217. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 218. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 219. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 220. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 221. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 223. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 224. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 225. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 226. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 227. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 229. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 230. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 231. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 232. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 233. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 235. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 236. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 237. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 238. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 239. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 241. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 242. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 243. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 244. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 245. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 246. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 247. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 248. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LABORATORY & TESTING SERVICES, 2018-2032 (USD MILLION)
TABLE 249. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 250. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 251. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Pharmaceutical Contract Manufacturing & Research Services market report include:
  • AbbVie Inc
  • Almac Group
  • Amanta Healthcare Ltd.
  • Aragen Life Sciences Ltd.
  • Automatic Liquid Packaging Solutions LLC
  • Baxter Pharmaceutical Solutions LLC
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent, Inc
  • Curida AS
  • Dalton Pharma Services
  • Evonik Industries AG
  • Famar Group
  • Horizon Pharmaceuticals, Inc
  • Laboratorios SALVAT, S.A
  • Lonza Group Ltd.
  • Nephron Pharmaceuticals Corporation
  • Pfizer, Inc.
  • Recipharm AB
  • Rommelag SE & Co. KG
  • Rusoma Laboratories Private Limited
  • Silgan Unicep
  • Unither Pharmaceuticals SAS
  • UPM Pharmaceuticals, Inc.
  • Woodstock Sterile Solutions

Table Information

Report AttributeDetails
No. of Pages197
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 237.2 Billion
Forecasted Market Value ( USD ) by 2032 $ 444.03 Billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Contract Type, Production Scale, Application - Global Forecast 2026-2032 - Product Image

Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Contract Type, Production Scale, Application - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market - Global Forecast 2026-2032 - Product Image

Oral Solid Dosage Contract Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
High Potency API Contract Manufacturing - Global Strategic Business Report - Product Image

High Potency API Contract Manufacturing - Global Strategic Business Report

  • Report
  • 466 Pages
  • Global
From
Generic Pharmaceuticals Contract Manufacturing - Global Strategic Business Report - Product Image

Generic Pharmaceuticals Contract Manufacturing - Global Strategic Business Report

  • Report
  • 494 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market (5th Edition): Trends and Forecast Till 2035, Geographical Regions and Key Players - Product Image

Pharmaceutical Contract Manufacturing Market (5th Edition): Trends and Forecast Till 2035, Geographical Regions and Key Players

  • Report
  • 545 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.